SILVERARC CAPITAL MANAGEMENT, LLC Relmada Therapeutics, Inc. Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$14.54M
portfolio value

Relmada Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 put Increase 0.00% 393K shares 14.54M $37.02 393K
Q3 2021 share Decrease -100.00% -46.72K shares -1.49M $26.21 0
Q2 2021 share Increase 0.00% 46.72K shares 1.49M $32.01 46.72K